X0508 4 2023-07-17-05:00 false 0000924515 GUIDED THERAPEUTICS INC GTHP 0001348439 Imhoff John E 5835 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS GA 30092 true false true false false Common Stock 2023-07-17-05:00 4 J false 26301 A 4436637 D Common Stock 2023-08-11-05:00 4 P false 500899 A 4937536 D Common Stock 2023-08-21-05:00 4 J false 112568 A 5050104 D Series E Preferred Stock 0.25 2023-08-11-05:00 4 P false 250 A 2023-08-11-05:00 Common Stock 1000000 250 D These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.2139. These shares were issued as part of Common Stock Purchase Agreement signed between Dr. Imhoff and Rosalind Master Fund, LLP, on August 3, 2023. For a price of $150,090, Dr. Imhoff purchased 500,899 shares of Guided Therapeutics' (GTHP) common stock, par value $0.001 and 250 shares of GTHP Series E Convertible Preferred Stock (see (3)). These securities consist of Series E Convertible Preferred Stock ("Series E Preferred") of the Issuer that are presently convertible on a 1-for-4,000 basis into Common Stock without payment or further consideration. The Series E Preferred shares are convertible at any time until 8/21/2025. The Series E Preferred has no expiration date. These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777. /s/ John E. Imhoff 2023-09-07-05:00